BridGene Biosciences
PrivateLast Round
Series B
Extension
Oct 16, 2025
Total Funding Raised
$79.02M
Company Overview
BridGene Biosciences is a biotechnology company focused on developing therapeutics for traditionally untreatable targets by leveraging advanced technologies such as covalent chemistry, chemical proteomics, and quantitative mass spectrometry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BridGene Biosciences Comps
Public and private peers based on sector, stage, and business model.
BridGene Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Oct 16, 2025 | ||||
| Series B | Jul 27, 2022 | ||||
| Series A | May 5, 2021 | ||||
| Grant | Sep 10, 2020 | ||||
| Grant | Sep 15, 2018 |
BridGene Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DYEE Capital | Series B |
| National Cancer Institute | Grant |
| Kaitai Capital | Series A |
| Junson Capital | Series B |
| Lapam Capital | Series B Extension, Series B |
| Grains Valley Venture Capital | Series B Extension |
| Proxima Ventures | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 5, 2026
Nobel laureate Bruce A. Beutler, M.D. joins the board.
- Oct 23, 2025
Presenting three posters at the 2025 AACR-NCI-EORTC International Conference.
BridGene Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BridGene Biosciences's valuation, stock price, and market status.
